"The HPV test will be rolled out on February 4 to coincide with World Cancer Day," an official with Metropolis said ...

Metropolis Healthcare and Roche Diagnostics India introduce self-sampling HPV DNA test for cervical cancer screening at home.

This test detects 14 high-risk HPV types in a single tube and is a clinically validated, FDA-approved, and WHO-prequalified ...

Roche has secured a new FDA approval for its first companion diagnostic test aimed at identifying breast cancer patients with ...

Roche is the recipient of the new approval, getting the go-ahead from the US regulator for its PATHWAY HER2 (4B5) test to ...

Lipoprotein(a) has long been recognized as a critical marker for people at risk of cardiovascular disease. However, the health care industry has lacked the tools to tackle the problem.

The FDA has approved an expanded label for Roche’s PATHWAY anti-HER2/neu (4B5) Rabbit Monoclonal Primary Antibody test, which ...

Metropolis collaborates with Roche Diagnostics India to introduce self-sampling HPV DNA test for early detection of cervical cancer: Our Bureau, Bengaluru Monday, February 3, 2025 ...

Georgia Roche tried to recruit support for England in the historic Test against Australia at Allegiant Stadium after meeting ...